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Abstract. Literature regarding the outcome of maxillary sinus floor elevation to create
sufficient bone fraction to enable implant placement was systematically reviewed.
Bone fraction and implant survival rate were assessed to determine whether grafting
material or applied growth factor affected bone fraction. Trials where sinus floor
elevations with autogenous bone (controls) were compared with autogenous bone
combined with growth factors or bone substitutes, or solely with bone substitutes
(test groups) were identified; 12 of 1124 fulfilled all inclusion criteria. Meta-
analyses comparing the bone fraction after applying: autogenous bone; autologous
bone with growth factors (platelet rich plasma); or autogenous bone and bone
substitutes (bovine hydroxyapatite, bioactive glass, corticocancellous pig bone)
revealed no significant differences in bone formation after 5 months. A significantly
higher bone fraction was found in the autogenous bone group compared to the sole
use of b-tricalciumphosphate (P = 0.036). The one-year overall implant survival
rate showed no significant difference between implants. Bone substitutes combined
with autogenous bone provide a reliable alternative for autogenous bone as sole
grafting material to reconstruct maxillary sinus bony deficiencies, for supporting
dental implants after 5 months. Adding growth factors (platelet rich plasma) to
grafting material and the sole use of b-tricalciumphosphate did not promote bone
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Maxillary sinus floor elevation 161Application of dental implants to support
prosthetic constructions has evolved into a
viable alternative to conventional prosthe-
tic procedures. Implant procedures in the
posterior maxilla often pose a problem due
to insufficient pre-existing bone frac-
tion13,15,36. This is not restricted to edentu-
lous patients, but is also often observed in
partially dentate patients needing an
implant-based prosthodontic reconstruc-
tion in the posterior region of the maxilla.
The problem of an insufficient level of
bone4 to allow for reliable primary place-
ment of implants can be solved by a max-
illary sinus floor elevation procedure using
autogenous bone, bone substitutes or a
mixture of autogenous bone and bone sub-
stitutes as grafting materials. Augmenta-
tion of the maxillary sinus floor with an
autogenous bone graft, introduced by
BOYNE & JAMES3 and TATUM30, is a com-
monly used method for increasing vertical
bone height for insertion of dental implants.
During the maxillary sinus floor eleva-
tion procedure, the space created between
the residual maxillary ridge and the ele-
vated Schneiderian membrane is usually
filled with grafting material7,38. In this
way, a bone fraction is created that may
allow for reliable implant placement, either
simultaneously with the elevation proce-
dure when the residual ridge allows for
primary implant stability or as a second
stage after healing of the grafted site 3,13,22.
For sinus floor augmentation, autoge-
nous bone is the most commonly used
material and is still considered the gold
standard12,13,16,34, although numerous
alternative materials have been used with
variable results. Recent studies have
demonstrated that the mere lifting of the
sinus mucosal lining and simultaneous
placement of implants also can result in
bone formation without the use of a graft-
ing material17. Currently, this technique
only is applied for conditions allowing for
sufficient primary stability of implants
during placement and a sufficient width
of the alveolar crest but not for reconstruc-
tion in horizontal and vertical directions.
Autogenous bone grafts are the most
widely used6. Autografts are popular
because they have osteogenic, osteoinduc-
tive, osteoconductive properties, a high
number of viable cells and are rich in
growth factors. The viable cells consist
of osteoblasts, undifferentiated mesench-
ymal cells, monocytes and osteoclast pre-
cursor cells. These cells participate in the
remodelling and formation of the new
bone12. Alternatives such as bone substi-
tutes do not provide the cellular elements
necessary for osteogenesis and are only
osteoconductive32. These alternatives aresynthetic or most organic material has
been removed from the substitute material
during the fabrication process.
Donor site morbidity is a problem asso-
ciated with bone-harvesting techniques,
which can be reduced or avoided when
using bone substitutes39. Whether autoge-
nous bone should still be considered as the
grafting material of choice can be ques-
tioned. Can autogenous bone be (partially)
replaced by bone-substitutes? The length of
healing time required before placing
implants in a site grafted with a bone sub-
stitute remains unclear (usually a site recon-
structed with a bone substitute requires
longer before implant placement than a site
reconstructed with autogenous bone). Also,
whether a bone substitute can be applied
solely or always has to be combined with
autogenous bone remains unclear. Clini-
cians are keen to speed up healing, and
the effect of using platelet rich plasma
(PRP) has been studied for its presumed
effect of speeding up bone regeneration. It
has been speculated that growth factors that
are present in PRP could enhance healing of
the grafts and might counteract resorption
after augmentation1,18.
The effect of maxillary sinus floor ele-
vation on the survival of endosseous den-
tal implants has been reviewed
systematically in general terms in the
past2,14,37, but a detailed analysis of the
efficacy of using an autogenous bone graft
compared with bone substitutes and bone
growth factors on bone formation and
implants was not carried out. The authors
of the reviews discussed solely autoge-
nous bone or only bone substitutes, but
did not compare the treatment outcome of
various grafting materials with autoge-
nous bone serving as a control. Retrospec-
tive studies, case reports, prospective and
cohort studies were included in the
reviews mentioned above, so the conclu-
sions of the reviews were not based on the
most reliable type of clinical studies. The
consensus of the sixth European workshop
on periodontology9,33 emphasized the
research need to answer comparative
questions to establish the clinical benefit
of bone augmentation with respect to
alternative treatments and to compare dif-
ferent treatments in terms of, amongst
others, effectiveness, adverse effects and
morbidity. In a recent Cochrane review,
ESPOSITO et al.8 discussed the effectiveness
of sinus lift procedures for dental implant
rehabilitation. No statistically significant
difference was observed for any of the
interventions evaluated. Conclusions are
based on a few trials, usually underpow-
ered, with short follow-up periods, and
often judged to be at high risk of bias,therefore they should be viewed as pre-
liminary and interpreted with caution.
Analysis of the efficacy of using an auto-
genous bone graft compared with bone
substitutes and bone growth factors on
bone formation and implant survival
was not studied.
The aim of this study was systemati-
cally to review the literature regarding the
treatment outcome of residual maxillary
ridges needing maxillary sinus floor ele-
vation surgery to create sufficient bone
fraction for reliable implant placement
in humans. The objectives of this systema-
tic review were to assess the bone fraction
and implant survival rate and to determine
whether the bone fraction is affected by
the grafting material or growth factor
applied.
Material and methods
For this review, a thorough search of the
literature was conducted in the electronic
databases MEDLINE (1979–September
2010, via PUBMED) and EMBASE
(1987–September 2010). Studies in which
patients were treated with a maxillary
sinus floor elevation with autogenous bone
as a control group were searched. Three
types of intervention were considered:
solely bone substitutes; autogenous bone
in combination with bone substitutes; and
autogenous bone in combination with
growth factors. Outcome measures were
bone fraction after healing period and
implant survival.
The search strategy used was a combina-
tion of MeSH terms and free text words;
‘Maxilllary sinus lift’[Mesh] OR (sinus
augmentation) OR (sinus floor elevation)
OR (maxillary sinus lift) OR (sinus graft)
AND ‘Dental Prosthesis, Implant-Suppor-
ted’[Mesh] OR ‘Implants, Experimental’
[Mesh] OR ‘Prostheses and Implants’[-
Mesh] OR ‘Dental Implants’[Mesh] OR
‘Dental Implantation, Endosseous’[Mesh]
OR ‘Dental Abutments’[Mesh] OR (alveo-
lar atrophy) OR (implant*) OR (dental
implant*) OR (oral implant*) AND
(Humans[Mesh]). No language restrictions
were applied.
The references of each relevant review
and eligible study were checked. The titles
and abstracts of the searches were assessed
independently by two examiners. Full text
documents were obtained for possibly
relevant articles. Manual searches of the
bibliographies of all full text articles and
related reviews selected from the electro-
nic search were also performed and com-
pleted the review.
Longitudinal studies (randomized con-
trolled trials, cohort studies) were consid-
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Identi fied  articles   





- No full  te xt availa ble 
- Unclea rly inte rventi on 
- Improper stud y design 
Includ ed for full t ext analysis 
n=39 
n=27articlesExcluded (see online appendix) 
-     No autogenous bone as control group 
-     Improper stud y design 
-     Randomization unclear 
-     No histomorph ometric anal ysis 
- No full  te xt availa ble 
Included for  methodological app rai sal, 
data extraction and analysis results  
n= 12 (Table  1)
Fig. 1. Steps in the systematic review.ered for evaluation. Patients with maxil-
lary atrophy, who had undergone a max-
illary sinus lift, were included. Only
studies in which autogenous bone was
used as a control group were chosen as
autogenous bone is considered the gold
standard and is considered to be accom-
panied by the highest level of bone
growth, at least during the first months
after grafting. Including an autogenous
bone group as a control also better allows
for comparison of the various studies.
There were three types of intervention:
solely bone substitutes; autogenous bone
in combination with bone substitutes;
autogenous bone in combination with
growth-factors. Outcome measures were
bone fraction after the healing period and
implant survival after at least 1-year fol-
low-up in patients with alveolar atrophy
treated with a sinus lift procedure. This
sinus lift was performed with autogenous
bone alone (control group) compared to
autogenous bone in combination with
growth factors or bone substitutes, or
solely with bone substitutes (test groups).
Retrospective studies, studies with an
inadequate study design, or an unclear
intervention, case series, technical reports
and reviews were excluded. Articles that
were not topic related, with no full texts
were excluded. Language was not
restricted.
Two reviewers independently assessed
the methodological quality using the
forms ‘quality assessment of a cohort
study’ and ‘quality assessment of a rando-
mized clinical trial’ developed by the
Dutch Cochrane Centre, a centre of the
Cochrane Collaboration (www.cochra-
ne.nl). These two validity tools consist
of eight and nine items, respectively,
which have to be scored with a plus, minus
or a question mark. It was decided that
studies scoring four or more plusses were
considered methodologically acceptable.
The two observers independently gener-
ated a score for the included articles. No
blinding for author, institute or journal
was performed. The main items of quality
assessment were: Was the study rando-
mized and the randomization procedure
clearly stated? How good was the alloca-
tion concealment? Was a clear description
of study group, inclusion and exclusion
criteria, intervention and outcomes given?
Was a clear description of withdrawals
and drop outs given? Disagreements on
validity assessment were resolved by dis-
cussion.
For each study the following data were
extracted and recorded on a data sheet:
study design (randomized controlled trial
or prospective cohort study); treatment(control versus test); number of patients;
type of patient (edentulous or not); details
of type of intervention; number of sinus
floor elevations and implants placed;
details of the outcomes (new bone forma-
tion) and implant survival; follow-up time.
Statistical analysis
With respect to the quality assessment,
agreement between the two reviewers
regarding eligible studies was expressed
using Cohen’s unweighted kappa. Failure
rates were calculated by dividing the num-
ber of events (failures or complications) in
the numerator by the total exposure time
(implant time) in the denominator. The
numerator was in all cases extracted
directly from the publication or was pro-
vided by the authors of the original papers
in cases in which only a part of the full
sample was taken into consideration. The
exposure time was extracted and calcu-
lated by multiplying the mean follow-uptime by the number of implants available
in the given statistical analysis. The mean
follow-up was directly extracted from the
articles. For each study, event rates for
implants were calculated by dividing the
total number of events by the implants’
exposure time in years.
A meta-analysis was carried out for
evaluating bone fraction. Random effect
models were created and a standardized
weighted mean difference was used to
evaluate bone fraction. Meta-analysis
was performed using the statistical soft-
ware package ‘Meta-analysis’ (Compre-
hensive Meta-analysis Version 2.2,
Biostat, Englewood NJ, USA (2005),
www.meta-analysis.com).
Results
The search in MEDLINE and EMBASE
provided 1124 articles reporting maxillary
sinus floor elevation in combination with
dental implant placement. Fig. 1 outlines























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































.the study selection procedure. Articles
which were not topic related, with no full
texts were excluded. Also studies with an
improper study design or an unclear inter-
vention, case series, technical reports and
reviews were excluded (n = 1085). The k-
value for inter-reviewer agreement on the
methodological appraisal was 0.85. Dis-
agreement was generally caused by slight
differences in interpretation and was
easily resolved in a consensus discussion.
39 articles were selected for full-text
analysis. Of these, 27 further articles had
to be excluded because they did not satisfy
the inclusion criteria (see the appendix
available online). These articles were
excluded because of inadequate study
design (not longitudinal, not prospective
or unclear description of randomization),
for not executing histomorphometric ana-
lysis or for not including autogenous bone
as a control group (details of the excluded
studies are given in the online appendix).
Authors who did not describe randomiza-
tion clearly were contacted via e-mail for
additional information. When a proper ran-
domization procedure was applied, these
studies were added to the results1,11,21,28.
The 12 articles that fulfilled the inclu-
sion criteria were randomized clinical
trials and had applied a split mouth design.
There were considerable differences in the
selected articles regarding the number of
patients, residual bone height, graft mate-
rials used, whether implants were placed
or not and follow-up. There were some
differences in data reporting and in inclu-
sion and exclusion criteria in the studies.
Description of studies
In all eligible maxillary sinus floor eleva-
tion studies autogenous bone was used as a
control group. The three types of interven-
tion were: solely bone substitutes; auto-
genous bone in combination with bone
substitutes; autogenous bone in combina-
tion with growth-factors. Outcome mea-
sures were bone fraction after healing
period and implant survival.
In the studies included, patients had
been treated with autogenous bone, auto-
genous bone in combination with bone
substitutes or PRP (Table 1). In 5 of the
12 studies, the patients were edentulous, in
the others edentulous and dentate patients
were treated. In five publications the num-
ber of implants placed, the implant survi-
val rate and follow-up was mentioned. To
determine an overall survival rate, a com-
prehensive meta-analysis of these five
studies was performed (Table 2).
The morphometric methods for analys-
ing the biopsies used in the included stu-
164 Rickert et al.













1 year in %
BETTEGA et al.2 AB 55 12 55 years and 0 months 0 0 0 100
RAGHOEBAR et al.22 AB 15 20.2 25 years and 3 months 0 0 0 100
SZABO et al.27 AB 40 6 20 years and 0 months 1 5 5 95.1
ZIJDERVELD et al.40 AB 16 11 14 years and 5 months 0 0 0 100
HALLMAN et al.11 AB 33 12 33 years and 0 months 6 18 7.4 83.4
Fixed 2.8 1.8 97.2
BETTEGA et al.2 AB + PRP 56 12 56 years and 0 months 0 0 0 100
RAGHOEBAR et al.22 AB + PRP 15 20.2 25 years and 3 months 1 4 4 96.1
SZABO et al.27 b-TCP 40 6 20 years and 0 months 1 5 5 95.1
ZIJDERVELD et al.40 b-TCP 15 11 13 years and 6 months 0 0 0 100
HALLMAN et al.11 AB + Bio-Oss1 35 12 35 years and 0 months 2 5.7 4 94.5
Fixed 1.8 1.1 98.2
AB: autogenous bone; PRP: platelet rich plasma; b-TCP: b-tricalciumphosphate; SE: standard error; exposure time: calculated by multiplying the
mean follow-up time by the number of implants available.dies were comparable. Quantitative and
qualitative investigations of the biopsies
were performed with light microscopy and
a computerized image analysis system was
applied to analyse bone formation in the
histological sections.
Histomorphometric results
Quantitative data analysis (bone fraction)
of the data provided in the 12 studies was
executed. Bone fraction was defined as the
percentage of the total bone fraction. In
the various meta-analyses performed,
results 5 months after sinus floor augmen-
tation were used because most included
studies showed histomorphometric results
after 5–6 months.
Regarding PRP, CONSOLO et al.5 showed
a significant difference in bone fraction in
areas reconstructed with a combination of
autogenous bone and PRP (40%) or solely
with autogenous bone (29%) at 4 and 5
months after sinus floor elevation. Biop-
sies taken after 6 and 7 months did not
show any statistical difference. By con-
trast, BETTEGA et al.2, RAGHOEBAR et al.22
and SCHAAF et al.24 did not observe any
significant difference between both treat-
ments, at the 3 and 6 months evaluations.
A meta-analysis of the four included arti-
cles failed to show a significant effect of
PRP, as the calculated pooled difference
[95% CI] in bone fraction was 0.398
[0.796 to 0.001]; (P = 0.341).
b-Tricalciumphosphate (Cerasorb) was
been used in the intervention groups in the
studies by SUBA et al.26, SZABO et al.27,
ZERBO et al.39 and ZIJDERVELD et al.40. A
meta-analysis of these revealed a signifi-
cantly higher bone fraction 5–6 months
after treatment when applying autogenous
bone (P = 0.036). The calculated pooled
difference [95% CI] in bone fraction was0.987 [0.216–1.758]. In the controls, aug-
mented with autogenous bone, the newly
formed bone was mostly lamellar, mature
bone (80%). In the b-tricalciumphosphate
sites, the newly formed bone was at com-
parable time points more immature and
had a predominantly woven character
(74%) 39.
Regarding bioactive glass TADJOEDIN
et al.28 showed that augmentation with
autogenous bone had resulted in a signifi-
cantly higher bone fraction (42%) than
treatment with bioactive glass (35%) 4
and 5 months after sinus floor elevation.
TURUNEN et al.35 presented comparable
results for both groups after 4 months of
healing. In the control group 25% of new
bone was seen and in the test group 26%.
A meta-analysis of the included studies
showed no difference in bone fraction
(P = 0.372), thus treatment with autoge-
nous bone alone was shown to be as good
as treatment with a combination from
autogenous bone and bioactive glass when
allowing for 5 months’ healing. The cal-
culated pooled difference [95% CI] in
bone fraction was 0.532 [1.523 to
0.534].
Regarding pig bone, BARONE et al.1
compared autogenous bone with a combi-
nation of autogenous bone and pig bone
particles. There were no significant differ-
ences 5 months after treatment with auto-
genous bone alone or in combination with
pig bone particles when allowing for 5
months’ healing (control 70%  19.9, test
67%  14.9).
Regarding Bio-Oss1, HALLMAN et al.11
used autogenous bone in combination with
Bio-Oss1 (20–80%) in the test group and
showed comparable results in both groups
6 months after sinus floor elevation. The
corresponding values for the bone fraction
area parameter were 38%  31.3 (controlgroup) and 40%  8 (test group). A third
treatment group was composed of patients
who accepted the treatment with a two
stage sinus lift with 100% Bio-Oss1. The
mean healing time for this group was
prolonged to an average of 8.5 months
because the newly formed bone was too
immature after 6 months to provide
enough primary stability for dental
implant placement. In this group, bone
fraction was 42%  26.6, after a healing
time of 8.5 months. Results from this
group are not included in the analysis
because it was not compared with an
autogenous bone group.
Implant survival
Implants inserted in grafts composed of
bone substitutes alone, bone substitutes
combined with growth factors, or a mix-
ture of autogenous bone and substitutes,
all achieved a 1-year survival rate as high
as implants placed in autogenous bone
alone (Tables 1 and 2). The overall
implant survival rate from these studies
was 97% for the control group treated with
autogenous bone alone and 98% for the
various test groups (Table 2). Implant
survival was defined as the percentage
of implants initially placed that was still
present at follow-up, 1 year after implant
placement and is calculated as 1  event
rate.
Discussion
From this systematic review of the litera-
ture, evaluating studies in which the bone
fraction after sinus floor elevation surgery
was evaluated by histomorphological ana-
lysis, it is obvious that adequate bone
formation in a created space (e.g. the space
created between the residual maxillary
Maxillary sinus floor elevation 165ridge and the elevated Schneiderian mem-
brane) can be achieved with a variety of
materials when a reasonable healing per-
iod (5–6 months) is allowed. According to
the findings of the present study, there is
no clinical evidence for the superiority of
autogenous bone grafts over most bone
substitutes in sinus floor elevation proce-
dures when allowing for such a healing
period. As the iliac crest is commonly used
as a donor site for patients who need a
bilateral, vertical maxillary sinus lift,
replacement of autogenous bone by bone
substitutes might decrease the morbidity
and discomfort of the grafting procedure
from the patient’s perspective.
In this study, autogenous bone served as
a control group. It has been shown that the
bone fraction measured in an area grafted
with autogenous bone was comparable to
that grafted with (a mixture of autogenous
bone and) bone substitutes when allowing
for a reasonably long healing period of at
least 5 months11. A comparable bone frac-
tion is also present in areas grafted with
autogenous bone alone after shorter heal-
ing periods (3–4 months23) thus allowing
for earlier implant placement in such sites.
It has been speculated that growth fac-
tors that are present in PRP could enhance
healing of the grafts and also counteract
resorption after augmentation31. Various
authors concluded that no relevant differ-
ences in healing of soft tissues and bone
existed between sites reconstructed with
autogenous bone and autogenous bone
mixed with PRP2,22,24. Four trials evalu-
ated the possible advantage of using PRP
to accelerate bone healing for sinus aug-
mentation2,5,22,24. No clinical benefit
could be observed in a meta-analysis of
these studies when using PRP, in other
words there is no scientific support for
justifying its use in application.
Meta-analyses comparing bone fraction
after applying b-tricalciumphosphate
revealed a significantly higher bone frac-
tion 5–6 months after treatment when
applying autogenous bone (P = 0.036).
SZABO et al.27 showed after a 6 month
healing period comparable results for both
groups. ZERBO et al.39 and ZIJDERVELD
et al.40 concluded that in the controls,
augmented with autogenous bone, the
newly formed bone was significantly
higher than in the b-tricalciumphosphate
group after the same healing period.
Bioactive glass, a material that has been
shown to be able to bond directly chemi-
cally to bone, is a potentially applicable
grafting material for reconstructive proce-
dures. When applied in the size range of
300–355 mm, bioactive glass showed
osteoconductive properties28,29. TURUNENet al.35 showed that the combined use of
bioactive glass granules with autogenous
bone chips for augmentation of the max-
illary sinus floor diminished the amount of
bone needed for augmentation and
resulted in the same quantity of bone as
when autogenous bone chips alone were
used. TADJOEDIN et al.28 showed in the
control group, using bioactive glass parti-
cles in combination with autogenous bone,
that new bone formation increased rapidly
within 2 months, from 29% at 4 months to
38% at 6 months. As the healing period is
sufficiently long (5 months), there are no
differences in treatment and bioactive
glass particles seem to be a good alter-
native for autogenous bone.
BARONE et al.1 compared autogenous
bone with a combination of autogenous
bone and pig bone particles. They found
no significant differences, 5 months after
treatment with autogenous bone alone or
in combination with pig bone particles
when allowing a 5-month healing time.
The use of bovine bone (Bio-Oss1) in
combination with autogenous bone offers
many advantages. First, it allows the
volume of the graft to be at least doubled,
avoiding the need to harvest large amounts
of autogenous bone. This advantage might
also apply to other substitutes. Second, the
osteoconductive properties of bovine bone
act as a scaffold that is essential for bone
remodelling. Third, bovine bone is a cal-
cium-deficient carbonate apatite with a
crystal size of approximately 10 nm,
therefore, the surface area of each graft
particle is considerably greater than that of
porous bioceramics, making its resorption
considerably slower 9. In addition, HALL-
MAN et al.11 concluded from their clinical
and histological study that similar short-
term results can be expected when using
autogenous bone, bovine hydroxyapatite,
or a mixture of both for maxillary sinus
floor augmentation and delayed placement
of dental implants.
In Table 2 the survival rate of implants
is shown. Implant survival rate was
defined as the percentage of implants pre-
sent at the 1-year follow-up. In some
studies, no implants were placed, nor
did the authors report on the implant sur-
vival rate or the follow-up period was less
than 1 year. The available data indicate
comparable implant survival in areas
reconstructed with either autogenous bone
alone or bone substitutes in combination
with autogenous bone. This is also sup-
ported by the results from NKENKE &
STELZLE19. When using autogenous bone
alone, the healing period can be reduced to
an average of 3 months, whereas it is at
least 5 months when using a bone sub-stitute either alone or in combination with
autogenous bone.
Several systematic reviews and meta-
analyses have been performed on studies
in which patients underwent sinus floor
elevation. For example, the objective of
the study by GRAZIANI et al.10 was to
review implant survival following sinus
floor augmentation procedures with con-
ventional implant placement in the poster-
ior maxilla. This systematic review
suggests that implant survival in the aug-
mented maxillary sinus is more variable
(36–100%) than that of implants placed in
the posterior maxilla (73–100%). This
study is restricted because of the limited
data from controlled trails comparing
implant survival in the augmented max-
illary sinus and the posterior maxilla. PJE-
TURSSON et al.20 studied the surfaces of
implants and their failure rate. The best
results were obtained using rough surface
implants (98% implant survival after 3
years). The analysis in the study from
NKENKE & STELZLE19 considered whether
autogenous bone is superior to bone sub-
stitutes. This study was limited to titanium
implants with modified surfaces placed in
sites with 6 mm of residual bone height.
The evidence provides a low level of
support for selection of autogenous bone
or bone substitutes.
The reviews published in the interna-
tional literature did not have such strict
inclusion criteria as the current
review7,10,19,20. In the current systematic
review methodological quality was
assessed using specific study-design related
forms designed by the Dutch Cochrane
Collaboration. The results of the previous
systematic reviews are limited because stu-
dies that were not well designed were
included in the analysis, furthermore no
autogenous bone group as a control group
and/or no split mouth design was generally
used to compare different outcomes and
healing time was not always taken into
account. No homogeneity between the stu-
dies can be reached, which limits the ana-
lysis of the data.
A limitation of this systematic review
might be that studies comparing various
types of bone substitutes, but not including
autogenous bone as a control, were not
included, as the outcome of these studies
might be biassed in showing a higher for-
mation of bone with one substitute that
might surpass the level of bone growth as
observed in other studies by autogenous
bone alone. When autogenous bone had
been applied in those studies, it might have
been the case that it would have performed
better than the substitutes studied. Further-
more, histomorphometric analysis was
166 Rickert et al.required to allow for comparison of results.
Restrictions of the present review, including
multiple confounding variables such as type
of implant, membrane application, height of
the residual bone, timing of implant place-
ment, patients compliance and habits might
have influenced the outcomes 13.
In future, innovative techniques to pro-
mote bone healing or induction growth of
bone will be introduced. To reconstruct
bony defects, for example, adding mono-
nuclear stem cells derived from a bone
marrow aspirate to Bio-Oss1 has been
shown to result in bone forming kinetics
comparable to autogenous bone alone, after
a healing period of 3–4 months23,25. These
mononuclear stem cells can differentiate to
osteoblasts if they are added to a bony
matrix. The use of a grafting material to
perform a maxillary sinus floor elevation
procedure may become questionable as a
recent study has demonstrated that the mere
lifting of the sinus mucosal lining and
simultaneous placement of implants also
can result in bone formation17. Currently
this technique is only applied for conditions
allowing for sufficient primary stability of
implants during placement and a sufficient
width of the alveolar crest and not for larger
reconstruction in a horizontal or vertical
direction. Well designed studies will have
to be carried out to determine whether this
treatment will reliably result in induction of
bone growth.
Taking these limitations into account, it
can be concluded from the present systema-
tic review of the literature that bone sub-
stitutes, such as Bio-Oss1, bioactive glass
or corticocancellous pig bone in combina-
tion with autogenous bone, form an alter-
native for autogenous bone alone for
reconstructing bony deficiencies in the
maxillary sinus region, for supporting den-
tal implants when there is a healing period
of at least 5 months. When applying b-
tricalciumphosphate, the use of a mixture
with autogenous bone is preferred to allow
for a short healing period before implant
placement. There is no scientific support for
adding PRP to autogenous bone or bone
substitutes to speed up the healing time of
bone. Finally, short-term implant survival,
the major clinical outcome, is not influ-
enced by the various grafting procedures
applied when allowing for a sufficient heal-
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